Research Paper Volume 13, Issue 6 pp 8155—8176
FAM72 serves as a biomarker of poor prognosis in human lung adenocarcinoma
Figure 8. The functional pathways and gene alteration of FAM72A-D in LUAD. (A) Several pathways were enriched in FAM72A-D related LUAD, including the proliferation, EGFR signaling, undifferentiated cancer, lung cancer poor survival and cell cycle; (B, C) Genetic alteration in FAM72A-D and its association with OS of LUAD patients.